Is PALB2 p.Asp595= (c.1785T>C) pathogenic?

PALB2 p.Asp595= (c.1785T>C) is classified Benign/Likely benign in PALB2 (ClinVar, Multiple submitters, 6 submitters; last evaluated 2025-01-14). Very rare (popmax 0.00133%, afr); Associated with hereditary neoplastic syndrome.

What condition is associated with PALB2 p.Asp595= (c.1785T>C)?

PALB2 p.Asp595= (c.1785T>C) is associated with hereditary neoplastic syndrome, hereditary breast carcinoma (ClinVar).

How common is PALB2 p.Asp595= (c.1785T>C) in the general population?

PALB2 p.Asp595= (c.1785T>C) is very rare (popmax 0.00133%, afr) (gnomAD).

PALB2 p.Asp595=

c.1785T>C · rs1555460651 · VCV460911

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 6 submitters

gnomAD v4.1

Rare

very rare (popmax 0.00133%, afr)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -5.1	GERP -3.6
Overall
CADD	0.035	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00133% African / African-American · 1/74,948 alleles

Overall 0.000124% 2/1,614,026 alleles · very rare exomes 1/1,461,816 · genomes 1/152,210 · joint denominator

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.00133%	74,948
South Asian	0.0011%	91,082

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: PALB2
Protein: p.Asp595=
Coding: c.1785T>C
MANE Select: NM_024675
dbSNP: rs1555460651
Type: single nucleotide variant
Location: chr16:23630369 (GRCh38)
Gene constraint: LOEUF 0.9 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 54.07 · 4 PDB
Residue 595: a UniProt-annotated variant site (risk factor for brovca5); a UniProt-annotated variant site (in fancn; risk factor for brovca5)

Full PALB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary breast carcinoma

Similar variants

PALB2 p.Asp595Tyr Uncertain significance ★★ ⚠ same residue
PALB2 p.Asp595Asn Conflicting classifications of pathogenicity ★ ⚠ same residue
PALB2 p.Asp595Glu Uncertain significance ★ ⚠ same residue
PALB2 p.Asp595Gly Conflicting classifications of pathogenicity ★ ⚠ same residue
PALB2 p.Asp595Val Uncertain significance ★ ⚠ same residue
PALB2 p.Asp595Ala Likely benign ★ same residue
PALB2 p.Asp595fs Pathogenic/Likely pathogenic ★★ same residue
PALB2 p.Asp595His Uncertain significance ⚠ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/palb2-p-asp595 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown